Guselkumab Improves Work Productivity, Daily Activity in Pso

In an analysis of the DISCOVER-2 trial, guselkumab treatment reduced impairment in work productivity and improved general health status in PsA over 2 years.

Related Keywords

United States , Jeffreyr Curtis , , University Of Alabama At Birmingham , Work Productivity , Activity Impairment Questionnaire , Euroqol Visual Analog Scale , General Health Through , Guselkumab Treatment , Patients With Active Psoriatic , Rheumatol Ther ,